In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
First Internet Bancorp (NASDAQ:INBK) reported its Q4 2024 earnings, revealing an EPS of $0.80, missing analysts' expectations of $0.92. However, the company exceeded revenue forecasts, reporting ...